Keʻena Honua

Kekemapa 3, 2024, ua ʻāpono ʻia ka lāʻau lapaʻau hou ʻo Zepzelca (lurbinectedin no ka injection) no ke kūʻai aku ʻana e ka National Medical Products Administration (NMPA) o Kina ma o ka papahana loiloi koʻikoʻi. Ua hōʻike ʻia ka lāʻau lapaʻau no ka mālama ʻana i nā poʻe maʻi makua me ka metastatic small cell lung ca...E heluhelu hou aku»

Ma ka lā 31 o Dekemaba, ua ʻāpono ka ʻĀina Hoʻokele Huahana Lapaʻau Lahui o Kina (NMPA) iā VYLOYTM (zolbetuximab), i hui pū ʻia me ka chemotherapy fluoropyrimidine- a me platinum, no ka mālama mua ʻana i nā maʻi me ka ulu ʻana o ka epidermal kanaka metastatic a i ʻole ka ulu ʻana o ka ʻōpū i hoʻomohala ʻole ʻia ma kahi kūloko.E heluhelu hou aku»

Kekemapa 31, 2024, ua loaʻa iā Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Hui") ka ʻae kūʻai aku ma Kina mai ka National Medical Products Administration (NMPA) no ka programmed cell death ligand1(PD-L1)-directed innovative humanized monoclonal antibody ("mAb") tagitanlim...E heluhelu hou aku»

ʻO C-CAR031 kahi lāʻau lapaʻau autologous, armored GPC3-targeting chimeric antigen receptor T-Cell (CAR-T), e aʻo ʻia nei no ka mālama ʻana iā HCC. Hoʻokumu ʻia ia ma luna o kahi CAR-T GPC3-targeting hou i hoʻolālā ʻia e AstraZeneca me ka hoʻohana ʻana i kā lākou dominant negative transforming growth factor-beta receptor II dominant negati...E heluhelu hou aku»

Kekemapa 20, 2024, ua ʻāpono ka National Medical Products Administration (NMPA) o Kina i kahi New Drug Application (NDA) o DOVBLERON ® (taletrectinib adipate capsule), kahi hanauna hou o ROS1 tyrosine kinase inhibitor (TKI), no ka mālama ʻana i nā maʻi makua me ka ROS holomua kūloko a i ʻole metastatic...E heluhelu hou aku»

ʻO C-CAR031 kahi lāʻau lapaʻau autologous, armored GPC3-targeting chimeric antigen receptor T-Cell (CAR-T), e aʻo ʻia nei no ka mālama ʻana i ka HCC. Ua hōʻike waha ʻia ka holomua o ka noiʻi o C-CAR031 i ka hepatocellular carcinoma (HCC) ma ka hālāwai makahiki o ka American Society of Clinical Oncology (ASCO) h...E heluhelu hou aku»

He lāʻau lapaʻau cell autologous ʻo GT101 i hana ʻia me ka TIL i hoʻonui ʻia a hoʻoulu hou ʻia mai ka puʻupuʻu ponoʻī o ka mea maʻi. Hoʻokele ʻia ka lāʻau lapaʻau ma ka ʻohi ʻana i nā ʻiʻo puʻupuʻu mai nā mea maʻi a me ka unuhi ʻana i ka TIL. A laila e hoʻonui ʻia ka TIL i unuhi ʻia me ka hoʻohana ʻana i ka paepae hana ponoʻī a Grit Bio ʻo StemTe...E heluhelu hou aku»

ʻO nā pūnaewele TAEST16001 he mau pūnaewele T autologous i hana ʻia ma ke ʻano genetic e hōʻike ana i ka receptor T-cell NY-ESO-1-kikoʻī kiʻekiʻe (TCR) e kuhikuhi ana iā NY-ESO-1 (i hōʻike ʻia ma kahi ākea o nā tumors) positive soft tissue sarcoma (STS) ma ke ʻano o HLA-A * 02: 01. He haʻawina pae I o nā maʻi me ka S holomua ...E heluhelu hou aku»

Kekemapa 04, 2024, ua hāʻawi ʻia ka New Drug Application (NDA) no ka hui pū ʻana o TYVYT® (sintilimab injection) a me ELUNATE® (fruquintinib) i ka ʻae ʻia ma Kina no ka mālama ʻana i nā maʻi me ka maʻi ʻaʻai endometrial holomua me nā puʻupuʻu Mismatch Repair proficient (pMMR) i loaʻa ...E heluhelu hou aku»

ʻO GC203 kahi lāʻau lapaʻau TIL i hoʻololi ʻia i ka gene vector non-viral i hoʻomohala ʻia me ka hoʻohana ʻana i ka paepae hoʻonui cell DeepTIL® ponoʻī a Juncell Therapeutics a me ka paepae hoʻololi gene NovaGMP®. Hiki iā DeepTIL® ke hoʻoikaika i nā TIL e lawa ka ikaika ʻaʻole pono ka hui pū ʻana o IL-2 ma hope o ka hoʻokomo ʻana, a...E heluhelu hou aku»

ʻO Glioblastoma Multiforme (GBM) kekahi o nā maʻi kanesa make loa, a kokoke i nā poʻe maʻi āpau e ʻike hou i ka maʻi ma muli o ke kūlana mālama o kēia manawa no ka GBM i ʻike hou ʻia. Hōʻike ka GBM hou (rGBM) i kahi ola waena ma lalo o 8 mau mahina me nā koho therapeutic palena. ʻO TX103 kahi CAR-T ce...E heluhelu hou aku»

ʻO RD13-02 kahi huahana kelepona CAR-T ākea e kuhikuhi ana iā CD7 i loaʻa mai nā mea hāʻawi olakino, a ua manaʻo ʻia no ka mālama ʻana i ka leukemia/lymphoma lymphoblastic acute T-cell (T-ALL/LBL) i hoʻihoʻi ʻia a i ʻole refractory. Ua hoʻololi ʻia ke ʻano genetic e pale aku i ka fratricide, ka maʻi graft-versus-host (GvHD), a me ka host-versus-...E heluhelu hou aku»